Overcoming barriers and stigma: new frontiers in solid organ transplantation for people with HIV.

IF 19 1区 医学 Q1 MICROBIOLOGY Clinical Microbiology Reviews Pub Date : 2024-03-14 Epub Date: 2024-01-19 DOI:10.1128/cmr.00111-22
K Storm, C M Durand
{"title":"Overcoming barriers and stigma: new frontiers in solid organ transplantation for people with HIV.","authors":"K Storm, C M Durand","doi":"10.1128/cmr.00111-22","DOIUrl":null,"url":null,"abstract":"<p><p>There is a growing need for solid organ transplantation (SOT) for people living with human immunodeficiency virus (HIV). With the advent of antiretroviral therapy, people living with HIV are experiencing increased life expectancies and are, therefore, developing more comorbidities, including end-stage organ disease. In cases of advanced organ failure, SOT is often the best therapeutic option to improve quality of life and overall survival. As organ shortages persist, transplantation of organs from donors with HIV to recipients with HIV has become a potential therapeutic option. This article first reviews the current state of organ transplantation from donors without HIV to recipients with HIV (HIV D-/R+) by organ and discusses key lessons learned from these transplant trials, including those about drug-drug interactions, rejection, and opportunistic infections. It then explores transplantation from donors with HIV to recipients with HIV (HIV D+/R+), a new frontier. Finally, it investigates challenges of implementation, including public awareness and regulatory requirements, and explores future directions for SOT in people living with HIV.</p>","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":" ","pages":"e0011122"},"PeriodicalIF":19.0000,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10938893/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/cmr.00111-22","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/19 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

There is a growing need for solid organ transplantation (SOT) for people living with human immunodeficiency virus (HIV). With the advent of antiretroviral therapy, people living with HIV are experiencing increased life expectancies and are, therefore, developing more comorbidities, including end-stage organ disease. In cases of advanced organ failure, SOT is often the best therapeutic option to improve quality of life and overall survival. As organ shortages persist, transplantation of organs from donors with HIV to recipients with HIV has become a potential therapeutic option. This article first reviews the current state of organ transplantation from donors without HIV to recipients with HIV (HIV D-/R+) by organ and discusses key lessons learned from these transplant trials, including those about drug-drug interactions, rejection, and opportunistic infections. It then explores transplantation from donors with HIV to recipients with HIV (HIV D+/R+), a new frontier. Finally, it investigates challenges of implementation, including public awareness and regulatory requirements, and explores future directions for SOT in people living with HIV.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
克服障碍和耻辱:艾滋病病毒感染者实体器官移植的新领域。
摘要人类免疫缺陷病毒(HIV)感染者对实体器官移植(SOT)的需求与日俱增。随着抗逆转录病毒疗法的出现,艾滋病病毒感染者的预期寿命延长,因此出现了更多的合并症,包括终末期器官疾病。在晚期器官衰竭的情况下,SOT 通常是改善生活质量和总体存活率的最佳治疗方案。随着器官短缺问题的持续存在,将感染 HIV 的捐赠者的器官移植给感染 HIV 的受者已成为一种潜在的治疗选择。本文首先按器官回顾了从未感染 HIV 的捐献者到感染 HIV 的受者(HIV D-/R+)的器官移植现状,并讨论了从这些移植试验中吸取的主要经验教训,包括有关药物相互作用、排斥反应和机会性感染的经验教训。然后,报告探讨了从感染艾滋病毒的捐献者到感染艾滋病毒的受者(HIV D+/R+)的移植,这是一个新的领域。最后,研究了实施过程中面临的挑战,包括公众意识和监管要求,并探讨了艾滋病毒感染者 SOT 的未来发展方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Microbiology Reviews
Clinical Microbiology Reviews 医学-微生物学
CiteScore
54.20
自引率
0.50%
发文量
38
期刊介绍: Clinical Microbiology Reviews (CMR) is a journal that primarily focuses on clinical microbiology and immunology.It aims to provide readers with up-to-date information on the latest developments in these fields.CMR also presents the current state of knowledge in clinical microbiology and immunology.Additionally, the journal offers balanced and thought-provoking perspectives on controversial issues in these areas.
期刊最新文献
Group B streptococcal infections in pregnancy and early life. The challenges of difficult-to-treat Acinetobacter infections. Laboratory detection of carbapenemases among Gram-negative organisms Animal models for exploring Chagas disease pathogenesis and supporting drug discovery Enriching the future of public health microbiology with hybridization bait capture
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1